BioDelivery Sciences International (BDSI) Highlighted As Weak On High Volume

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified BioDelivery Sciences International ( BDSI) as a weak on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified BioDelivery Sciences International as such a stock due to the following factors:

  • BDSI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $24.6 million.
  • BDSI has traded 323,125 shares today.
  • BDSI is trading at 5.09 times the normal volume for the stock at this time of day.
  • BDSI is trading at a new low 6.03% below yesterday's close.

'Weak on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news, analyst downgrades, insider selling, selling from 'superinvestors,' or that hedge funds and traders are piling out of a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize (or avoid losses by trimming weak positions). In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in BDSI with the Ticky from Trade-Ideas. See the FREE profile for BDSI NOW at Trade-Ideas

If you liked this article you might like

3 Biotech Stocks on Readers' Minds

Trump's FDA: A Friendlier Biotech Sheriff

2 Recovering Biotech Names With Room to Run

4 Undervalued Biotech Stocks

2 Oversold Biopharmas With Big 2017 Upsides